Dimethylamine

Dimethylamine

SCHEMBL6883348

CNC.O=C(O)c1ccccc1C(=O)c1ccccc1O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
HPGD P15428 2/20 0.63
KDM4E B2RXH2 1/20 0.63
CA12 O43570 1/20 0.63
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
HMGB1 P09429 1/20 0.63
CA4 P22748 1/20 0.63
CA6 P23280 1/20 0.63
CA7 P43166 1/20 0.63
CA9 Q16790 1/20 0.63
NAPRT Q6XQN6 1/20 0.63
CA14 Q9ULX7 1/20 0.63
AKR1C3 P42330 3/20 0.59
KMT2A Q03164 2/20 0.56
GSTA1 P08263 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL8606279 0.92 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
SCHEMBL1334176 0.92 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
SCHEMBL11665831 0.90 ALDH1A1 (0.71) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
Salicylic Acid SCHEMBL3409946 0.88 ALDH1A1 (0.82) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
Diethylamine SCHEMBL3323938 0.86 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
Phthalic Acid SCHEMBL11577907 0.84 AKR1C3 (0.76) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
SCHEMBL455832 0.83 LIG1 (0.64) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
Phthalic Acid SCHEMBL5875168 0.83 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
Phthalic Acid SCHEMBL5875176 0.83 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2HPGDKDM4ECA12
2-Benzoylbenzoic Acid SCHEMBL11757908 0.82 AKR1C3 (0.87) ALDH1A1KDM4ECA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242891-A1 Production of keto acids CAMPBELL JONATHAN (GB) 2004-12-02 US disclosed
EP-1442009-A1 PRODUCTION OF KETO ACIDS Ciba SC Holding AG (CH) 2004-08-04 EP disclosed
WO-2003037846-A1 PRODUCTION OF KETO ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242891-A1 Production of keto acids PKLR, KHK, ME1 ALDH1A1 1103/4885SMN1; SMN2 3961/4885HPGD 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.